

Decoding Stem Cell Rejuvenation Factors (Markus Gstöttner, CEO of Clock.bio)
Nov 20, 2024
Markus Gstöttner, CEO of Clock.bio, brings his diverse experience from public service and cultured meat entrepreneurship to the forefront of stem cell research. He discusses groundbreaking work on induced pluripotent stem cells (iPSCs) that may reverse aging effects. Gstöttner reveals significant findings from a genetic screen identifying over 150 rejuvenation-related genes. The conversation also highlights the potential of strategic partnerships and drug repurposing in advancing therapies aimed at extending healthspan and tackling age-related diseases.
Chapters
Transcript
Episode notes